Product image of Medikinet (Methylphenidate Hydrochloride) supplied by GNH India

Medikinet

Active Ingredient:
Methylphenidate Hydrochloride
Origin:
EU

Medikinet (Methylphenidate Hydrochloride)

Methylphenidate Hydrochloride, the active ingredient in Medikinet, is a central nervous system stimulant presented as an oral tablet for oral use. It is prescribed to manage attention deficit hyperactivity disorder and narcolepsy in patients requiring improved focus and wakefulness.

GNH India supplies Medikinet as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides reliable logistics for global distribution, including regulatory compliance, temperature‑controlled shipping where required, and comprehensive documentation.

Manufacturer / TM Owner

Medice Arzneimittel Pütter Gmbh & Co. Kg

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Medikinet, a central nervous system stimulant, is indicated for the treatment of attention deficit hyperactivity disorder and narcolepsy, conditions that affect attention, impulse control, and daytime alertness.

  • Attention deficit hyperactivity disorder in children and adolescents: improves sustained attention, reduces impulsivity and hyperactivity, facilitating better school performance and social interactions.
  • Attention deficit hyperactivity disorder in adults: enhances concentration, decreases distractibility, and supports occupational functioning and daily responsibilities.
  • Narcolepsy: reduces excessive daytime sleepiness, lessens cataplexy episodes, and improves overall wakefulness and quality of life.

How It Works

  • Methylphenidate Hydrochloride blocks the reuptake of dopamine and norepinephrine at neuronal synapses, increasing their extracellular concentrations. The heightened catecholamine activity enhances neurotransmission in brain regions responsible for attention, arousal, and impulse control, thereby improving focus and reducing excessive daytime sleepiness.

Side Effects

Common Side Effects

  • Insomnia: difficulty falling or staying asleep.
  • Decreased appetite: reduced hunger leading to potential weight loss.
  • Headache: mild to moderate head pain.
  • Nausea: feeling of sickness or urge to vomit.
  • Stomach pain: abdominal discomfort.

Serious or Rare Side Effects

  • Cardiovascular events: hypertension, tachycardia, or arrhythmias.
  • Psychiatric symptoms: new or worsening anxiety, agitation, or psychosis.
  • Severe allergic reactions: rash, swelling, or anaphylaxis.
  • Priapism: prolonged painful erection.
  • Seizures: convulsive episodes in susceptible individuals.

Precautions & Warnings

Before initiating therapy, clinicians should evaluate patient history and monitor ongoing safety.

  • Cardiovascular assessment: review history of heart disease, hypertension, or arrhythmias.
  • Psychiatric monitoring: observe for emergence or worsening of anxiety, mood changes, or psychotic symptoms.
  • Growth monitoring: regularly measure height and weight in pediatric patients.
  • Potential for abuse: prescribe only when clearly indicated and monitor for misuse.
  • Drug interaction review: assess concomitant medications for possible interactions.
  • Store at ambient temperature: keep in original container, protect from moisture and heat.

Avoid Interactions

Methylphenidate may interact with several drug classes, requiring careful assessment.

Major Interactions (Avoid)

  • Monoamine oxidase inhibitors (MAOIs): risk of hypertensive crisis.
  • Other central nervous system stimulants: increased cardiovascular and CNS stimulation.

Moderate Interactions (Monitor Closely)

  • Antidepressants (SSRIs, SNRIs, tricyclics): may amplify stimulant effects.
  • Antihypertensive agents: possible reduction in blood pressure control.
  • Antacids or acidic beverages: may affect drug absorption.

Frequently Asked Questions

Medikinet is prescribed for attention deficit hyperactivity disorder (ADHD) and narcolepsy. In ADHD it helps improve focus, reduce hyperactivity, and support academic or work performance. In narcolepsy it lessens excessive daytime sleepiness and cataplexy, promoting better wakefulness.

Methylphenidate hydrochloride blocks the reuptake of dopamine and norepinephrine, increasing their levels in the brain. The elevated neurotransmitters enhance signaling in pathways that regulate attention, impulse control, and arousal, leading to improved concentration and reduced sleepiness.

The appropriate dose of Medikinet is determined individually by a qualified prescriber based on the patient’s age, condition severity, and response to therapy. Dosage adjustments are made according to clinical judgment and patient monitoring.

Safety of Medikinet in pregnancy or while breastfeeding has not been definitively established. Healthcare providers should weigh potential benefits against possible risks and discuss alternative options when treating pregnant or nursing individuals.

To request Medikinet, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details, and necessary import documentation.

Medikinet belongs to the class of central nervous system stimulants, similar to other methylphenidate formulations and amphetamine‑based products. Compared with non‑stimulant options, it typically offers a faster onset of action and may provide greater symptom control, but individual response and side‑effect profiles vary.

Medikinet should be stored at ambient temperature, below 25 °C, in its original packaging. Keep the product away from moisture, direct sunlight, and excessive heat to maintain stability and potency.

Medikinet is taken orally, usually with a glass of water. It may be taken with or without food, but patients should follow the prescribing physician’s instructions regarding timing and any specific administration guidelines.

Serious risks include cardiovascular events such as hypertension or tachycardia, psychiatric symptoms like new or worsening anxiety or psychosis, severe allergic reactions, priapism, and seizures. Patients should be monitored closely for any of these adverse reactions.

Medikinet is contraindicated in individuals with known hypersensitivity to methylphenidate, those taking monoamine oxidase inhibitors, patients with severe cardiovascular disease, uncontrolled hypertension, or a history of serious psychiatric disorders where stimulants may exacerbate symptoms.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Methylphenidate Hydrochloride

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT